Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICON8: Weekly vs 3-Weekly Chemotherapy in Ovarian Cancer
NCT01654146Phase 3Unknown
- Sponsor
- Medical Research Council
- Start
- Jun 2011
- Primary completion
- Jun 2017
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection, carboplatin in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Medical Research Council. Status: unknown.
02
Drugs
Paclitaxel Micelles for Injectioncarboplatin
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT01654146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01654146.